25 XP   0   0   10

Arvinas Inc
Buy, Hold or Sell?

Let's analyse Arvinas together

PenkeI guess you are interested in Arvinas Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arvinas Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Arvinas Inc

I send you an email if I find something interesting about Arvinas Inc.

Quick analysis of Arvinas (30 sec.)










What can you expect buying and holding a share of Arvinas? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$9.69
Expected worth in 1 year
$11.09
How sure are you?
31.0%

+ What do you gain per year?

Total Gains per Share
$1.40
Return On Investment
4.1%

For what price can you sell your share?

Current Price per Share
$34.29
Expected price per share
$20.10 - $53.08
How sure are you?
50%

1. Valuation of Arvinas (5 min.)




Live pricePrice per Share (EOD)

$34.29

Intrinsic Value Per Share

$-38.60 - $-46.35

Total Value Per Share

$-28.91 - $-36.65

2. Growth of Arvinas (5 min.)




Is Arvinas growing?

Current yearPrevious yearGrowGrow %
How rich?$660m$645m-$122.1m-23.4%

How much money is Arvinas making?

Current yearPrevious yearGrowGrow %
Making money-$91.5m-$69.8m-$21.6m-23.7%
Net Profit Margin-49.2%-228.6%--

How much money comes from the company's main activities?

3. Financial Health of Arvinas (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#83 / 1016

Most Revenue
#239 / 1016

Most Profit
#968 / 1016

Most Efficient
#539 / 1016

What can you expect buying and holding a share of Arvinas? (5 min.)

Welcome investor! Arvinas's management wants to use your money to grow the business. In return you get a share of Arvinas.

What can you expect buying and holding a share of Arvinas?

First you should know what it really means to hold a share of Arvinas. And how you can make/lose money.

Speculation

The Price per Share of Arvinas is $34.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arvinas.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arvinas, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.69. Based on the TTM, the Book Value Change Per Share is $0.35 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arvinas.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.27-6.6%-1.35-3.9%-1.04-3.0%-0.76-2.2%-0.66-1.9%
Usd Book Value Change Per Share2.988.7%0.351.0%-0.80-2.3%0.381.1%0.331.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.988.7%0.351.0%-0.80-2.3%0.381.1%0.331.0%
Usd Price Per Share41.16-28.24-47.02-44.51-31.72-
Price to Earnings Ratio-4.53--5.44--11.69--18.68--13.43-
Price-to-Total Gains Ratio13.82--66.32--58.92--60.43--61.10-
Price to Book Ratio4.25-3.61-4.90-7.49-6.47-
Price-to-Total Gains Ratio13.82--66.32--58.92--60.43--61.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share34.29
Number of shares29
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.350.38
Usd Total Gains Per Share0.350.38
Gains per Quarter (29 shares)10.1311.15
Gains per Year (29 shares)40.5144.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10413104535
20817208980
301221130134125
401621540178170
502031950223215
602432360267260
702842770312305
803243180357350
903653590401395
1004054000446440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.028.00.03.4%1.028.00.03.4%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%9.017.03.031.0%9.017.03.031.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%9.017.03.031.0%9.017.03.031.0%

Fundamentals of Arvinas

About Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

Fundamental data was last updated by Penke on 2024-04-11 01:07:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Arvinas Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Arvinas earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • A Net Profit Margin of 359.2% means that $3.59 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arvinas Inc:

  • The MRQ is 359.2%. The company is making a huge profit. +2
  • The TTM is -49.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ359.2%TTM-49.2%+408.3%
TTM-49.2%YOY-228.6%+179.4%
TTM-49.2%5Y-390.2%+341.0%
5Y-390.2%10Y-364.0%-26.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ359.2%-199.6%+558.8%
TTM-49.2%-213.0%+163.8%
YOY-228.6%-279.3%+50.7%
5Y-390.2%-438.4%+48.2%
10Y-364.0%-605.5%+241.5%
1.1.2. Return on Assets

Shows how efficient Arvinas is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • -11.9% Return on Assets means that Arvinas generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arvinas Inc:

  • The MRQ is -11.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.9%TTM-7.7%-4.1%
TTM-7.7%YOY-5.1%-2.6%
TTM-7.7%5Y-7.0%-0.8%
5Y-7.0%10Y-9.2%+2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%-13.5%+1.6%
TTM-7.7%-12.9%+5.2%
YOY-5.1%-11.8%+6.7%
5Y-7.0%-14.1%+7.1%
10Y-9.2%-16.0%+6.8%
1.1.3. Return on Equity

Shows how efficient Arvinas is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • -23.5% Return on Equity means Arvinas generated $-0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arvinas Inc:

  • The MRQ is -23.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.5%TTM-16.9%-6.5%
TTM-16.9%YOY-11.0%-5.9%
TTM-16.9%5Y-11.6%-5.3%
5Y-11.6%10Y-81.7%+70.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.5%-16.9%-6.6%
TTM-16.9%-16.1%-0.8%
YOY-11.0%-15.1%+4.1%
5Y-11.6%-19.9%+8.3%
10Y-81.7%-20.9%-60.8%

1.2. Operating Efficiency of Arvinas Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Arvinas is operating .

  • Measures how much profit Arvinas makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • An Operating Margin of 383.5% means the company generated $3.84  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arvinas Inc:

  • The MRQ is 383.5%. The company is operating very efficient. +2
  • The TTM is -62.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ383.5%TTM-62.5%+446.0%
TTM-62.5%YOY-223.0%+160.5%
TTM-62.5%5Y-403.7%+341.2%
5Y-403.7%10Y-375.5%-28.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ383.5%-295.1%+678.6%
TTM-62.5%-225.8%+163.3%
YOY-223.0%-288.4%+65.4%
5Y-403.7%-477.4%+73.7%
10Y-375.5%-625.6%+250.1%
1.2.2. Operating Ratio

Measures how efficient Arvinas is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of -2.84 means that the operating costs are $-2.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arvinas Inc:

  • The MRQ is -2.835.
  • The TTM is 1.625. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ-2.835TTM1.625-4.460
TTM1.625YOY3.262-1.638
TTM1.6255Y5.032-3.407
5Y5.03210Y5.877-0.845
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.8353.090-5.925
TTM1.6253.264-1.639
YOY3.2623.783-0.521
5Y5.0325.679-0.647
10Y5.8777.894-2.017

1.3. Liquidity of Arvinas Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Arvinas is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.98 means the company has $4.98 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arvinas Inc:

  • The MRQ is 4.979. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.934. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.979TTM3.934+1.045
TTM3.934YOY5.359-1.425
TTM3.9345Y7.589-3.655
5Y7.58910Y6.383+1.206
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9793.914+1.065
TTM3.9344.220-0.286
YOY5.3595.388-0.029
5Y7.5896.045+1.544
10Y6.3836.406-0.023
1.3.2. Quick Ratio

Measures if Arvinas is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • A Quick Ratio of 8.65 means the company can pay off $8.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arvinas Inc:

  • The MRQ is 8.646. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.159. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.646TTM7.159+1.487
TTM7.159YOY10.122-2.963
TTM7.1595Y13.153-5.994
5Y13.15310Y10.920+2.233
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6463.572+5.074
TTM7.1593.998+3.161
YOY10.1225.390+4.732
5Y13.1535.969+7.184
10Y10.9206.287+4.633

1.4. Solvency of Arvinas Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Arvinas assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arvinas to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49 means that Arvinas assets are financed with 49.4% credit (debt) and the remaining percentage (100% - 49.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arvinas Inc:

  • The MRQ is 0.494. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.550. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.494TTM0.550-0.056
TTM0.550YOY0.532+0.018
TTM0.5505Y0.380+0.170
5Y0.38010Y0.419-0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4940.336+0.158
TTM0.5500.334+0.216
YOY0.5320.269+0.263
5Y0.3800.366+0.014
10Y0.4190.390+0.029
1.4.2. Debt to Equity Ratio

Measures if Arvinas is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • A Debt to Equity ratio of 97.7% means that company has $0.98 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arvinas Inc:

  • The MRQ is 0.977. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.232. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.977TTM1.232-0.256
TTM1.232YOY1.137+0.095
TTM1.2325Y0.730+0.502
5Y0.73010Y10.091-9.361
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9770.382+0.595
TTM1.2320.396+0.836
YOY1.1370.335+0.802
5Y0.7300.434+0.296
10Y10.0910.465+9.626

2. Market Valuation of Arvinas Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arvinas generates.

  • Above 15 is considered overpriced but always compare Arvinas to the Biotechnology industry mean.
  • A PE ratio of -4.53 means the investor is paying $-4.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arvinas Inc:

  • The EOD is -3.770. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.526. Based on the earnings, the company is expensive. -2
  • The TTM is -5.443. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.770MRQ-4.526+0.755
MRQ-4.526TTM-5.443+0.917
TTM-5.443YOY-11.691+6.249
TTM-5.4435Y-18.680+13.238
5Y-18.68010Y-13.431-5.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.770-2.259-1.511
MRQ-4.526-2.569-1.957
TTM-5.443-2.664-2.779
YOY-11.691-4.120-7.571
5Y-18.680-6.258-12.422
10Y-13.431-6.171-7.260
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arvinas Inc:

  • The EOD is -7.015. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.420. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.520. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.015MRQ-8.420+1.405
MRQ-8.420TTM-5.520-2.900
TTM-5.520YOY-11.841+6.321
TTM-5.5205Y9.222-14.742
5Y9.22210Y4.944+4.278
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.015-2.924-4.091
MRQ-8.420-3.246-5.174
TTM-5.520-3.488-2.032
YOY-11.841-5.620-6.221
5Y9.222-8.315+17.537
10Y4.944-8.826+13.770
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Arvinas is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.25 means the investor is paying $4.25 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arvinas Inc:

  • The EOD is 3.537. Based on the equity, the company is fair priced.
  • The MRQ is 4.246. Based on the equity, the company is fair priced.
  • The TTM is 3.614. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.537MRQ4.246-0.709
MRQ4.246TTM3.614+0.632
TTM3.614YOY4.901-1.287
TTM3.6145Y7.485-3.871
5Y7.48510Y6.473+1.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.5371.851+1.686
MRQ4.2462.090+2.156
TTM3.6142.095+1.519
YOY4.9012.844+2.057
5Y7.4853.466+4.019
10Y6.4733.815+2.658
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Arvinas Inc.

3.1. Institutions holding Arvinas Inc

Institutions are holding 97.247% of the shares of Arvinas Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31EcoR1 Capital, LLC9.87977.18846726491125942823.0366
2023-12-31BlackRock Inc7.86510.005653548643852567.7522
2023-12-31Vanguard Group Inc7.12560.004448513902431675.2768
2023-12-31RTW INVESTMENTS, LLC6.18872.709421348342134830
2023-12-31T. Rowe Price Associates, Inc.5.62850.02123832123114345242.5285
2023-12-31Avidity Partners Management LP4.38454.4778298511737015714.1554
2023-12-31Bellevue Group AG3.68331.5789250773138253117.9998
2023-12-31FMR Inc3.2960.00712244019-2624276-53.9054
2023-12-31JPMorgan Chase & Co3.19140.008621728291835829.2287
2023-12-31Nextech Invest AG2.490513.001216956451408394490.3008
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)2.30580.71321569895-517397-24.788
2023-12-31New Leaf Venture Partners, L.L.C.1.89442.752128952100
2023-12-31State Street Corporation1.74270.00241186474270222.3306
2023-12-31Geode Capital Management, LLC1.64890.00481122627652376.1696
2023-12-31COMMODORE CAPITAL LP1.46883.5964100000010000000
2023-12-31Paradigm Biocapital Advisors LP1.36791.79479313039313030
2023-12-31NORGES BANK1.28920.006387770817595325.0733
2023-12-31Adage Capital Partners Gp LLC1.15960.06737894857894850
2023-12-31Morgan Stanley - Brokerage Accounts1.01860.002569347928915771.5165
2023-12-31Goldman Sachs Group Inc0.96780.0024658918464268238.5143
Total 68.596677.944246703102+10190202+21.8%

3.2. Funds holding Arvinas Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BB Biotech AG Ord3.11381.703212000000
2023-12-31T. Rowe Price New Horizons2.58550.2928176029051396041.2379
2023-12-31US Small-Cap Growth II Equity Comp2.58550.2918176029051396041.2379
2024-02-29Vanguard Total Stock Mkt Idx Inv2.13580.00431454137-4267-0.2926
2024-03-28iShares Russell 2000 ETF1.81430.0779123526756460.4592
2024-02-29Vanguard Small Cap Index1.77060.03941205483110590.9259
2023-12-31T. Rowe Price Health Sciences1.24880.237985023936623775.6685
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.19260.03668119856030.0743
2023-12-31Vanguard Explorer Inv1.06340.1394724005-95764-11.6818
2024-02-29JPM Global Healthcare C (acc) USD1.03670.7064705808-196419-21.7705
2023-12-31FIAM Small Cap Core Composite1.01150.726688677-296323-30.0836
2024-02-29Vanguard Small Cap Growth Index Inv0.99380.0892676640112501.6907
2024-02-29JPMorgan Small Cap Growth A0.96420.7455656494-619-0.0942
2024-01-31FIAM Small Cap Core CIT Cl B0.91080.6789620100-68577-9.9578
2024-01-31Fidelity Small Cap Index0.73010.083249709179481.6249
2023-12-31UBS: US Equity Small Cap Growth0.70370.809747910614720144.3503
2024-03-28iShares Biotechnology ETF0.62030.228442229900
2024-03-28iShares Russell 2000 Growth ETF0.60930.147414844-482-0.1161
2023-12-19Nomura ACI AdvMed Impact Inv MF0.52641.223335838060801.7258
2023-12-31Candriam Global Equities Oncology0.51150.7723482545000016.7642
Total 26.12869.032717789389+971493+5.5%

3.3. Insider Transactions

Insiders are holding 2.56% of the shares of Arvinas Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-23John G HoustonSELL519647.05
2024-02-23Ronald PeckSELL169947.05
2024-02-23Sean A CassidySELL170247.05
2023-08-11Ronald PeckSELL132424.39

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Arvinas Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.9790.349+753%-0.796+127%0.384+675%0.334+791%
Book Value Per Share--9.6947.681+26%9.475+2%6.853+41%4.911+97%
Current Ratio--4.9793.934+27%5.359-7%7.589-34%6.383-22%
Debt To Asset Ratio--0.4940.550-10%0.532-7%0.380+30%0.419+18%
Debt To Equity Ratio--0.9771.232-21%1.137-14%0.730+34%10.091-90%
Dividend Per Share----0%-0%-0%-0%
Eps---2.274-1.349-41%-1.037-54%-0.757-67%-0.664-71%
Free Cash Flow Per Share---1.222-1.288+5%-1.029-16%-0.161-87%-0.129-89%
Free Cash Flow To Equity Per Share--3.6950.088+4093%-1.012+127%0.795+365%0.616+500%
Gross Profit Margin--1.0111.003+1%1.000+1%1.001+1%1.000+1%
Intrinsic Value_10Y_max---46.348--------
Intrinsic Value_10Y_min---38.602--------
Intrinsic Value_1Y_max---0.993--------
Intrinsic Value_1Y_min---0.973--------
Intrinsic Value_3Y_max---5.767--------
Intrinsic Value_3Y_min---5.449--------
Intrinsic Value_5Y_max---13.895--------
Intrinsic Value_5Y_min---12.657--------
Market Cap2334597068.160-20%2802333488.6401922349029.440+46%3201475375.840-12%3030482650.944-8%2159762298.130+30%
Net Profit Margin--3.592-0.492+114%-2.286+164%-3.902+209%-3.640+201%
Operating Margin--3.835-0.625+116%-2.230+158%-4.037+205%-3.755+198%
Operating Ratio---2.8351.625-275%3.262-187%5.032-156%5.877-148%
Pb Ratio3.537-20%4.2463.614+17%4.901-13%7.485-43%6.473-34%
Pe Ratio-3.770+17%-4.526-5.443+20%-11.691+158%-18.680+313%-13.431+197%
Price Per Share34.290-20%41.16028.235+46%47.023-12%44.511-8%31.722+30%
Price To Free Cash Flow Ratio-7.015+17%-8.420-5.520-34%-11.841+41%9.222-191%4.944-270%
Price To Total Gains Ratio11.512-20%13.818-66.319+580%-58.920+526%-60.433+537%-61.105+542%
Quick Ratio--8.6467.159+21%10.122-15%13.153-34%10.920-21%
Return On Assets---0.119-0.077-35%-0.051-57%-0.070-41%-0.092-22%
Return On Equity---0.235-0.169-28%-0.110-53%-0.116-50%-0.817+248%
Total Gains Per Share--2.9790.349+753%-0.796+127%0.384+675%0.334+791%
Usd Book Value--660000000.000522950000.000+26%645075000.000+2%466586859.950+41%334372778.552+97%
Usd Book Value Change Per Share--2.9790.349+753%-0.796+127%0.384+675%0.334+791%
Usd Book Value Per Share--9.6947.681+26%9.475+2%6.853+41%4.911+97%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---2.274-1.349-41%-1.037-54%-0.757-67%-0.664-71%
Usd Free Cash Flow---83200000.000-87675000.000+5%-70075000.000-16%-10968741.650-87%-8754573.345-89%
Usd Free Cash Flow Per Share---1.222-1.288+5%-1.029-16%-0.161-87%-0.129-89%
Usd Free Cash Flow To Equity Per Share--3.6950.088+4093%-1.012+127%0.795+365%0.616+500%
Usd Market Cap2334597068.160-20%2802333488.6401922349029.440+46%3201475375.840-12%3030482650.944-8%2159762298.130+30%
Usd Price Per Share34.290-20%41.16028.235+46%47.023-12%44.511-8%31.722+30%
Usd Profit---154800000.000-91550000.000-41%-69875000.000-55%-51316444.800-67%-38145145.207-75%
Usd Revenue---43100000.00019625000.000-320%30950000.000-239%15687341.150-375%11804090.310-465%
Usd Total Gains Per Share--2.9790.349+753%-0.796+127%0.384+675%0.334+791%
 EOD+2 -6MRQTTM+25 -9YOY+18 -165Y+17 -1710Y+21 -13

4.2. Fundamental Score

Let's check the fundamental score of Arvinas Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.770
Price to Book Ratio (EOD)Between0-13.537
Net Profit Margin (MRQ)Greater than03.592
Operating Margin (MRQ)Greater than03.835
Quick Ratio (MRQ)Greater than18.646
Current Ratio (MRQ)Greater than14.979
Debt to Asset Ratio (MRQ)Less than10.494
Debt to Equity Ratio (MRQ)Less than10.977
Return on Equity (MRQ)Greater than0.15-0.235
Return on Assets (MRQ)Greater than0.05-0.119
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Arvinas Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.871
Ma 20Greater thanMa 5038.241
Ma 50Greater thanMa 10043.622
Ma 100Greater thanMa 20039.920
OpenGreater thanClose33.420
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  35,900-5,10030,80022,10052,900-20,00032,900-77,700-44,800
Total Revenue 38,000-5,50032,50022,00054,500-19,90034,600-77,700-43,100



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,304,600
Total Liabilities644,600
Total Stockholder Equity660,000
 As reported
Total Liabilities 644,600
Total Stockholder Equity+ 660,000
Total Assets = 1,304,600

Assets

Total Assets1,304,600
Total Current Assets1,280,200
Long-term Assets24,400
Total Current Assets
Cash And Cash Equivalents 317,200
Short-term Investments 949,300
Net Receivables 7,200
Other Current Assets 6,500
Total Current Assets  (as reported)1,280,200
Total Current Assets  (calculated)1,280,200
+/-0
Long-term Assets
Property Plant Equipment 14,000
Long-term Assets Other 10,400
Long-term Assets  (as reported)24,400
Long-term Assets  (calculated)24,400
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities257,100
Long-term Liabilities387,500
Total Stockholder Equity660,000
Total Current Liabilities
Short-term Debt 2,100
Accounts payable 17,600
Other Current Liabilities 74,400
Total Current Liabilities  (as reported)257,100
Total Current Liabilities  (calculated)94,100
+/- 163,000
Long-term Liabilities
Long term Debt 800
Capital Lease Obligations 2,400
Long-term Liabilities  (as reported)387,500
Long-term Liabilities  (calculated)3,200
+/- 384,300
Total Stockholder Equity
Common Stock100
Retained Earnings -1,332,700
Accumulated Other Comprehensive Income -3,100
Other Stockholders Equity 1,995,700
Total Stockholder Equity (as reported)660,000
Total Stockholder Equity (calculated)660,000
+/-0
Other
Capital Stock100
Cash and Short Term Investments 1,266,500
Common Stock Shares Outstanding 61,100
Current Deferred Revenue163,000
Liabilities and Stockholders Equity 1,304,600
Net Debt -313,800
Net Invested Capital 660,800
Net Working Capital 1,023,100
Property Plant and Equipment Gross 35,100
Short Long Term Debt Total 3,400



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
37,937
0
0
0
66,848
116,278
105,991
98,886
199,282
186,568
172,046
209,094
301,641
282,450
262,582
271,947
717,369
681,772
644,027
1,604,865
1,581,600
1,488,300
1,407,000
1,334,800
1,268,800
1,175,800
1,083,500
1,058,300
1,304,600
1,304,6001,058,3001,083,5001,175,8001,268,8001,334,8001,407,0001,488,3001,581,6001,604,865644,027681,772717,369271,947262,582282,450301,641209,094172,046186,568199,28298,886105,991116,27866,84800037,937
   > Total Current Assets 
37,282
35,557
0
0
65,529
114,443
103,693
95,518
195,678
179,736
163,261
199,663
290,881
270,195
249,582
257,980
703,088
664,657
627,734
1,576,151
1,552,500
1,457,000
1,376,400
1,304,700
1,240,200
1,148,200
1,056,700
1,033,000
1,280,200
1,280,2001,033,0001,056,7001,148,2001,240,2001,304,7001,376,4001,457,0001,552,5001,576,151627,734664,657703,088257,980249,582270,195290,881199,663163,261179,736195,67895,518103,693114,44365,5290035,55737,282
       Cash And Cash Equivalents 
5,088
-35,557
0
0
30,912
60,831
3,353
6,191
3,190
28,786
11,342
12,135
9,211
36,106
21,594
88,989
588,373
346,068
48,726
255,663
108,300
62,300
93,200
132,600
81,300
130,200
90,600
113,700
317,200
317,200113,70090,600130,20081,300132,60093,20062,300108,300255,66348,726346,068588,37388,98921,59436,1069,21112,13511,34228,7863,1906,1913,35360,83130,91200-35,5575,088
       Short-term Investments 
30,469
71,115
0
0
8,259
51,866
96,387
83,603
184,638
146,175
147,831
178,375
271,661
226,728
221,103
159,575
100,158
305,203
551,849
1,288,814
1,394,300
1,366,100
1,250,000
1,138,100
1,124,000
993,300
948,200
884,800
949,300
949,300884,800948,200993,3001,124,0001,138,1001,250,0001,366,1001,394,3001,288,814551,849305,203100,158159,575221,103226,728271,661178,375147,831146,175184,63883,60396,38751,8668,2590071,11530,469
       Net Receivables 
1,410
0
0
0
26,040
1,435
1,962
2,179
5,032
2,470
1,402
5,202
6,281
3,878
3,564
5,956
8,444
5,175
7,416
8,636
25,700
6,700
8,100
6,800
8,000
4,700
4,800
20,600
7,200
7,20020,6004,8004,7008,0006,8008,1006,70025,7008,6367,4165,1758,4445,9563,5643,8786,2815,2021,4022,4705,0322,1791,9621,43526,0400001,410
       Other Current Assets 
315
0
0
0
317
1,747
1,991
3,545
2,818
2,305
2,686
3,951
3,727
3,482
3,321
3,460
6,113
8,210
15,243
18,538
19,700
17,400
20,600
21,700
21,400
14,500
7,600
8,400
6,500
6,5008,4007,60014,50021,40021,70020,60017,40019,70018,53815,2438,2106,1133,4603,3213,4823,7273,9512,6862,3052,8183,5451,9911,747317000315
   > Long-term Assets 
0
0
0
0
1,320
1,814
2,298
3,368
3,604
6,832
8,785
9,430
10,761
12,255
13,000
13,968
14,281
17,116
16,293
28,714
29,100
31,300
30,600
30,100
28,600
27,600
26,800
25,300
24,400
24,40025,30026,80027,60028,60030,10030,60031,30029,10028,71416,29317,11614,28113,96813,00012,25510,7619,4308,7856,8323,6043,3682,2981,8141,3200000
       Property Plant Equipment 
634
0
0
0
1,299
1,814
2,278
3,347
3,583
6,811
8,764
9,410
10,734
12,226
12,971
13,939
14,252
17,087
16,264
15,879
16,600
19,200
18,900
18,800
17,800
17,300
16,700
15,700
14,000
14,00015,70016,70017,30017,80018,80018,90019,20016,60015,87916,26417,08714,25213,93912,97112,22610,7349,4108,7646,8113,5833,3472,2781,8141,299000634
       Long-term Assets Other 
0
0
0
0
21
-1,814
21
21
21
21
21
21
27
29
29
29
29
29
29
12,836
12,800
12,100
11,700
11,300
10,800
10,300
10,100
9,600
10,400
10,4009,60010,10010,30010,80011,30011,70012,10012,80012,83629292929292927212121212121-1,814210000
> Total Liabilities 
13,906
0
0
0
66,602
64,847
61,710
62,562
62,615
58,830
55,541
74,934
74,955
70,743
64,800
66,827
75,111
66,474
61,080
787,128
799,900
765,000
736,400
713,300
703,900
664,800
619,900
601,100
644,600
644,600601,100619,900664,800703,900713,300736,400765,000799,900787,12861,08066,47475,11166,82764,80070,74374,95574,93455,54158,83062,61562,56261,71064,84766,60200013,906
   > Total Current Liabilities 
10,034
0
0
0
17,855
17,274
17,311
19,848
22,980
20,600
20,946
29,396
32,813
33,169
33,720
39,531
49,085
40,372
41,820
182,508
261,700
238,000
238,200
244,600
295,100
282,900
306,900
317,300
257,100
257,100317,300306,900282,900295,100244,600238,200238,000261,700182,50841,82040,37249,08539,53133,72033,16932,81329,39620,94620,60022,98019,84817,31117,27417,85500010,034
       Short-term Debt 
141
454
0
0
159
164
169
195
154
648
719
597
674
900
921
940
953
1,217
1,221
1,123
1,100
1,700
1,700
1,800
1,800
2,000
2,000
2,100
2,100
2,1002,1002,0002,0001,8001,8001,7001,7001,1001,1231,2211,21795394092190067459771964815419516916415900454141
       Short Long Term Debt 
141
454
0
0
159
164
169
195
154
113
71
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
200
0
0200100100000000000000007111315419516916415900454141
       Accounts payable 
1,566
0
0
0
597
1,967
1,657
1,301
2,758
1,564
1,411
2,278
4,557
3,021
2,430
5,088
7,122
9,003
4,975
4,672
31,300
8,600
12,300
7,900
5,700
12,300
6,700
34,300
17,600
17,60034,3006,70012,3005,7007,90012,3008,60031,3004,6724,9759,0037,1225,0882,4303,0214,5572,2781,4111,5642,7581,3011,6571,9675970001,566
       Other Current Liabilities 
8,327
0
0
0
3,546
15,307
1,985
4,851
4,001
2,948
3,999
6,227
7,603
6,784
7,404
12,144
18,860
8,001
13,473
13,769
23,100
30,200
29,800
41,800
69,000
53,700
68,100
56,700
74,400
74,40056,70068,10053,70069,00041,80029,80030,20023,10013,76913,4738,00118,86012,1447,4046,7847,6036,2273,9992,9484,0014,8511,98515,3073,5460008,327
   > Long-term Liabilities 
0
0
0
0
48,748
109
44,399
42,714
39,635
38,230
34,595
45,538
42,142
37,574
31,080
27,297
26,026
26,103
19,259
604,620
538,200
527,000
498,200
468,700
408,800
381,900
313,000
283,800
387,500
387,500283,800313,000381,900408,800468,700498,200527,000538,200604,62019,25926,10326,02627,29731,08037,57442,14245,53834,59538,23039,63542,71444,39910948,7480000
       Long term Debt Total 
0
0
0
0
0
109
65
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
900
900
0
0
009009001,0001,0001,0001,0001,0001,0001,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0006510900000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
2,671
2,541
2,365
2,388
2,743
2,512
2,291
2,040
4,919
4,618
4,314
4,000
5,800
5,300
4,900
4,500
4,000
3,500
3,000
2,400
2,4003,0003,5004,0004,5004,9005,3005,8004,0004,3144,6184,9192,0402,2912,5122,7432,3882,3652,5412,671000000000
       Warrants
0
0
0
0
0
0
0
315,167
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000315,1670000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
40,714
37,635
2,137
32,595
43,538
40,142
35,574
29,080
25,297
24,026
24,103
18,259
603,620
537,200
526,000
497,200
467,700
407,800
381,000
312,100
0
0
00312,100381,000407,800467,700497,200526,000537,200603,62018,25924,10324,02625,29729,08035,57440,14243,53832,5952,13737,63540,7140000000
> Total Stockholder Equity
24,031
24,088
0
0
246
51,431
44,281
36,324
136,667
127,738
116,505
134,160
226,686
211,707
197,781
205,120
642,258
615,298
582,947
817,737
781,700
723,300
670,600
621,500
564,900
511,000
463,600
457,200
660,000
660,000457,200463,600511,000564,900621,500670,600723,300781,700817,737582,947615,298642,258205,120197,781211,707226,686134,160116,505127,738136,66736,32444,28151,4312460024,08824,031
   Common Stock
948
0
0
0
1,193
6
22
4
31
31
32
33
38
39
39
40
48
49
49
53
0
0
100
100
100
100
100
100
100
1001001001001001001000053494948403939383332313142261,193000948
   Retained Earnings Total Equity00-1,113,900-1,047,300-965,400-882,500-816,300-746,300-682,900-629,894-583,142-532,853-491,889-450,342-419,523-394,296-372,557-351,509-333,834-316,669-302,265-286,1770000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-10
0
-97
-47
-218
80
300
197
108
-603
1,664
1,080
561
-243
-487
-677
-4,600
-18,700
-22,000
-24,800
-19,200
-12,600
-12,200
-9,200
-3,100
-3,100-9,200-12,200-12,600-19,200-24,800-22,000-18,700-4,600-677-487-2435611,0801,664-60310819730080-218-47-970-100000
   Capital Surplus 
0
0
0
0
0
0
0
7,378
439,118
444,295
450,007
485,439
599,097
606,567
615,601
654,342
1,133,537
1,148,345
1,166,526
1,448,255
1,469,200
1,488,300
1,508,800
1,528,700
1,549,400
1,570,800
1,589,600
0
0
001,589,6001,570,8001,549,4001,528,7001,508,8001,488,3001,469,2001,448,2551,166,5261,148,3451,133,537654,342615,601606,567599,097485,439450,007444,295439,1187,3780000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
913
-32,879
0
0
1,177
1,265
205,094
7,378
439,118
444,295
450,007
485,439
599,097
606,567
615,601
654,342
1,133,537
1,148,345
1,166,526
1,448,255
1,469,200
1,488,300
1,508,800
1,528,700
1,549,400
1,570,800
1,589,600
1,644,200
1,995,700
1,995,7001,644,2001,589,6001,570,8001,549,4001,528,7001,508,8001,488,3001,469,2001,448,2551,166,5261,148,3451,133,537654,342615,601606,567599,097485,439450,007444,295439,1187,378205,0941,2651,17700-32,879913



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue78,500
Cost of Revenue-6,700
Gross Profit71,80071,800
 
Operating Income (+$)
Gross Profit71,800
Operating Expense-473,300
Operating Income-401,500-401,500
 
Operating Expense (+$)
Research Development379,700
Selling General Administrative100,300
Selling And Marketing Expenses6,700
Operating Expense473,300486,700
 
Net Interest Income (+$)
Interest Income32,300
Interest Expense-0
Other Finance Cost-0
Net Interest Income32,300
 
Pretax Income (+$)
Operating Income-401,500
Net Interest Income32,300
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-363,900-439,100
EBIT - interestExpense = -401,500
-366,400
-367,300
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-401,500-363,900
Earnings Before Interest and Taxes (EBITDA)-394,800
 
After tax Income (+$)
Income Before Tax-363,900
Tax Provision-10,100
Net Income From Continuing Ops-295,400-374,000
Net Income-367,300
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses480,000
Total Other Income/Expenses Net37,600-32,300
 

Technical Analysis of Arvinas
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arvinas. The general trend of Arvinas is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arvinas's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arvinas Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 35.42 < 51.51 < 53.08.

The bearish price targets are: 32.20 > 28.99 > 20.10.

Tweet this
Arvinas Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arvinas Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arvinas Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arvinas Inc. The current macd is -2.57203739.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arvinas price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Arvinas. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Arvinas price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Arvinas Inc Daily Moving Average Convergence/Divergence (MACD) ChartArvinas Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arvinas Inc. The current adx is 26.48.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Arvinas shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Arvinas Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arvinas Inc. The current sar is 38.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Arvinas Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arvinas Inc. The current rsi is 28.87. The current phase is Oversold in neutral market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in neutral market:
  • Trending up: The RSI is trending up. +1
Arvinas Inc Daily Relative Strength Index (RSI) ChartArvinas Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arvinas Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arvinas price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Arvinas Inc Daily Stochastic Oscillator ChartArvinas Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arvinas Inc. The current cci is -131.23650573.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Arvinas Inc Daily Commodity Channel Index (CCI) ChartArvinas Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arvinas Inc. The current cmo is -47.26873895.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Arvinas Inc Daily Chande Momentum Oscillator (CMO) ChartArvinas Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arvinas Inc. The current willr is -80.7569388.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Arvinas Inc Daily Williams %R ChartArvinas Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arvinas Inc.

Arvinas Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arvinas Inc. The current atr is 1.93626172.

Arvinas Inc Daily Average True Range (ATR) ChartArvinas Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arvinas Inc. The current obv is -2,688,314.

Arvinas Inc Daily On-Balance Volume (OBV) ChartArvinas Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arvinas Inc. The current mfi is 31.48.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Arvinas Inc Daily Money Flow Index (MFI) ChartArvinas Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arvinas Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Arvinas Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arvinas Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.871
Ma 20Greater thanMa 5038.241
Ma 50Greater thanMa 10043.622
Ma 100Greater thanMa 20039.920
OpenGreater thanClose33.420
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Arvinas with someone you think should read this too:
  • Are you bullish or bearish on Arvinas? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arvinas? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arvinas Inc

I send you an email if I find something interesting about Arvinas Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arvinas Inc.

Receive notifications about Arvinas Inc in your mailbox!